INVASIVE INTERVENTIONS IN STRUCTURAL HEART DISEASES: COMPREHENSIVE TECHNIQUES

Invasive Interventions in Structural Heart Diseases-kapak

TRANSTHORACIC ECHOCARDIOGRAPHY IN STRUCTURAL HEART DISEASE INTERVENTIONS

Nedret Ülvan

Bilkent City Hospital, Department of Cardiology, Ankara, Türkiye

Ülvan N. Transthoracic Echocardiography in Structural Heart Disease Interventions. In: Tanık VO, Özlek B, editors. Invasive Interventions in Structural Heart Diseases: Comprehensive Techniques. 1st ed. Ankara: Türkiye Klinikleri; 2025. p.15-26.

ABSTRACT

In recent years, the management of structural heart diseases (SHD) has significantly evolved due to the prevalent use of transcatheter techniques. The progression of transcatheter treatments has been made possible by advancements in devices and the development of imaging technologies. In this regard, cardiovascular imaging plays a crucial role not only in assessing SHD but also in guiding therapeutic interventions. To optimize these objectives, a multimodal imaging approach utilizing new tools for pre-procedural planning, intra-procedural guidance and follow-up is essential. Transthoracic echocardiography (TTE), as a non-invasive technique, provides essential information about the anatomy of the lesion and nearby structures, thereby allowing for effective planning prior to procedures.

Keywords: Structural heart disease; Transcatheter therapies; Imaging; Transthoracic echocardiography

Referanslar

  1. Douglas PS, Garcia MJ, Haines DE, Lai WW, Manning WJ, Patel AR, et al. Appropriate use criteria for echocardiography. J Am Soc Echocardiogr. 2011;24:229-67. [Link]
  2. Nishimura RA, Otto CM, Bonow RO, Carabello BA, Erwin JP 3rd, Guyton RA, et al. 2014 AHA/ACC Guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation. 2014;129:e521-643. [Crossref]
  3. Alfieri O, Maisano F, De Bonis M, Stefano PL, Torracca L, Oppizzi M, et al. The double-orifice technique in mitral valve repair: a simple solution for complex problems. J Thorac Cardiovasc Surg. 2001;122(4):674-681. [Crossref]  [PubMed]
  4. Del Forno B, De Bonis M, Agricola E, Melillo F, Schiavi D, Castiglioni A, et al. Mitral valve regurgitation: a disease with a wide spectrum of therapeutic options. Nat Rev Cardiol. 2020;17:807-27 [Crossref]  [PubMed]
  5. Wunderlich NC, Dalvi B, Ho SY, Küx H, Siegel RJ. Rheumatic Mitral Valve Stenosis: Diagnosis and Treatment Options. Curr Cardiol Rep. 2019;21(3):14. [Crossref]  [PubMed]
  6. Vahanian A, Alfieri O, Andreotti F, Antunes MJ, Barón-Esquivias G, Baumgartner H et al. Guidelines on the management of valvular heart disease (version 2012): The Joint Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS). Eur Heart J. 2012;33(19):2451-2496. [Link]
  7. Wilkins GT, Weyman AE, Abascal VM, Block PC, Palacios IF. Percutaneous balloon dilatation of the mitral valve: an analysis of echocardiographic variables related to outcome and the mechanism of dilatation. Br Heart J. 1988;60(4):299-308. [Crossref]  [PubMed]  [PMC]
  8. Salemi A, Worku BM, Standard imaging techniques in transcatheter aortic valve replacement. J Thorac Dis. 2017;9(Suppl 4):S289-S298. [Crossref]  [PubMed]  [PMC]
  9. Perry TE, George SA, Lee B, Wahr J, Randle D, Sigurðsson G. A guide for pre-procedural imaging for transcatheter aortic valve replacement patients. Perioper Med (Lond). 2020;9(1):36. [Crossref]  [PubMed]  [PMC]
  10. Zamorano JL, Goncalves A, Lang R. Imaging to select and guide transcatheter aortic valve implantation. Eur Heart J. 2014;35(24):1578-1587. [Crossref]  [PubMed]  [PMC]
  11. Leon MB , Smith CR., Mack M, Miller DC. Moses JW, Svensson LG et al. Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery. N Engl J Med. 2010;363(17):1597-1607. [Crossref]  [PubMed]
  12. Hahn RT, Zamorano JL. The need for a new tricuspid regurgitation grading scheme. Eur Hear J Cardiovasc Imaging. 2017;18(12):1342-1343. [Crossref]  [PubMed]
  13. Kadri AN, Menon V, Sammour YM, Gajulapalli RD, Meenakshisundaram C, Nusairat L, et al. Outcomes of patients with severe tricuspid regurgitation and congestive heart failure. Heart. 2019;105(23):1813-1817 [Crossref]  [PubMed]
  14. Martinez RM, O'Leary PW, Anderson RH. Anatomy and echocardiography of the normal and abnormal tricuspid valve. Cardiol Young. 2006;16(Suppl 3):4-11 [Crossref]  [PubMed]
  15. Zaidi A, Oxborough D, Augustine DX, Bedair R, Harkness A, Rana B et al .Echocardiographic assessment of the tricuspid and pulmonary valves: a practical guideline from the British Society of Echocardiography. Echo Res Pract. 2020 Dec;7(4):G95-G122. [Crossref]  [PubMed]  [PMC]
  16. Zoghbi WA, Adams D, Bonow RO, Enriquez-Sarano M, Foster E, Grayburn PA, et al. Recommendations for noninvasive evaluation of native valvular regurgitation: a report from the American Society of Echocardiography developed in collaboration with the Society for Cardiovascular Magnetic Resonance. Journal of the American Society of Echocardiography 2017;30:303-3. [Crossref]  [PubMed]
  17. Silvestry FE, Cohen MS, Armsby LB, Burkule NJ, Fleishman CE, Hijazi ZM, et al. Guidelines for the Echocardiographic Assessment of Atrial Septal Defect and Patent Foramen Ovale: From the American Society of Echocardiography and Society for Cardiac Angiography and Interventions. J Am Soc Echocardiogr. 2015;28(8):910-9. [Crossref]  [PubMed]
  18. Baumgartner H, De Backer J, Babu-Narayan SV, Budts W, Chessa M, Diller GP. ESC Scientific Document Group , 2020 ESC Guidelines for the management of adult congenital heart disease: The Task Force for the management of adult congenital heart disease of the European Society of Cardiology (ESC). Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC), International Society for Adult Congenital Heart Disease (ISACHD), European Heart Journal, 2021;42(6):563-645. [Crossref]  [PubMed]
  19. Nagueh SF, Bierig SM, Budoff MJ, Desai M, Dilsizian V, Eidem B, et al. American Society of Echocardiography; American Society of Nuclear Cardiology; Society for Cardiovascular Magnetic Resonance; Society of Cardiovascular Computed Tomography. American Society of Echocardiography clinical recommendations for multimodality cardiovascular imaging of patients with hypertrophic cardiomyopathy: endorsed by the American Society of Nuclear Cardiology, Society for Cardiovascular Magnetic Resonance, and Society of Cardiovascular Computed Tomography. J Am Soc Echocardiogr. 2011;24:473-498. [Crossref]  [PubMed]
  20. Afonso LC, Bernal J, Bax JJ, Abraham TP. Echocardiography in hypertrophic cardiomyopathy: the role of conventional and emerging technologies. JACC Cardiovasc Imaging. 2008;1:787-800. [Crossref]  [PubMed]
  21. Maron MS, Olivotto I, Zenovich AG, Link MS, Pandian NG, Kuvin JT, et al. Hypertrophic cardiomyopathy is predominantly a disease of left ventricular outflow tract obstruction. [Link]
  22. Panza JA, Petrone RK, Fananapazir L, Maron BJ. Utility of continuous wave Doppler echocardiography in the noninvasive assessment of left ventricular outflow tract pressure gradient in patients with hypertrophic cardiomyopathy. J Am Coll Cardiol. 1992;19:91-99. [Crossref]  [PubMed]
  23. Ommen SR, Mital S, Burke MA, Day SM, Deswal A, Elliott P, et al. 2020 AHA/ACC Guideline for the diagnosis and treatment of patients with hypertrophic cardiomyopathy: Executive summary: A report of the American College of Cardiology/American Heart Association Joint CommitTÖE on Clinical Practice Guidelines. Circulation. 2020;142:e558-e631. [Crossref]  [PubMed]
  24. Ommen SR, Maron BJ, Olivotto I, Maron MS, Cecchi F, Betocchi S, et al. Long-term effects of surgical septal myectomy on survival in patients with obstructive hypertrophic cardiomyopathy. J Am Coll Cardiol. 2005;46(3):470-476. [Link]
  25. Sitges M, Qin JX, Lever HM, Bauer F, Drinko JK, Agler DA, et al. Evaluation of left ventricular outflow tract area after septal reduction in obstructive hypertrophic cardiomyopathy: a real-time 3-dimensional echocardiographic study. Am Heart J. 2005;150(4):852-858. [Crossref]  [PubMed]
  26. van Dockum WG, Beek AM, ten Cate FJ, ten Berg JM, Bondarenko O, Götte MJ, et al. Early onset and progression of left ventricular remodeling after alcohol septal ablation in hypertrophic obstructive cardiomyopathy. Circulation. 2005;111(19):2503-2508. [Crossref]  [PubMed]
  27. Mazur W, Nagueh SF, Lakkis NM, Middleton KJ, Killip D, Roberts R, et al. Regression of left ventricular hypertrophy after nonsurgical septal reduction therapy for hypertrophic obstructive cardiomyopathy. Circulation. 2001;103(11):1492-1496. [Crossref]  [PubMed]
  28. Braunwald E. A new treatment for hypertrophic cardiomyopathy? Eur Heart J. 1997;18:709-710. [Crossref]  [PubMed]
  29. Hammermeister K, Sethi GK, Henderson WG, Grover FL, Oprian C, Rahimtoola SH. Outcomes 15 years after valve replacement with a mechanical versus a bioprosthetic valve: final report of the Veterans Affairs randomized trial. J Am Coll Cardiol. 2000;36(4):1152-1158. [Crossref]  [PubMed]
  30. Ionescu A, Fraser A G, Butchart E G. Prevalence and clinical significance of incidental paraprosthetic valvar regurgitation: a prospective study using transoesophageal echocardiography. Heart. 2003;89(11):1316-1321. [Crossref]  [PubMed]  [PMC]
  31. Rallidis L S, Moyssakis I E, Ikonomidis I, Nihoyannopoulos P. Natural history of early aortic paraprosthetic regurgitation: a five- year follow- up. Am Heart J. 1999;138(2 Pt 1):351-357. [Crossref]  [PubMed]
  32. Davila-Roman VG, Waggoner AD, Kennard ED, Holubkov R, Eric Jamieson WR, Englberger L, et al. Prevalence and severity of paravalvular regurgitation in the Artificial Valve Endocarditis Reduction Trial (AVERT) echocardiography study. J Am Coll Cardiol. 2004;44(7):1467-1472. [Crossref]  [PubMed]
  33. Dvir D, Barbash IM, Ben-Dor I, Torguson R, Badr S, Minha S, et al. Paravalvular regurgitation after transcatheter aortic valve replacement: diagnosis, clinical outcome, preventive and therapeutic strategies. Cardiovasc Revasc Med. 2013;14(3):174-181. [Crossref]  [PubMed]